Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 11:3:181.
doi: 10.3389/fgene.2012.00181. eCollection 2012.

MeCP2 as a genome-wide modulator: the renewal of an old story

Affiliations

MeCP2 as a genome-wide modulator: the renewal of an old story

Floriana Della Ragione et al. Front Genet. .

Abstract

Since the discovery of MeCP2, its functions have attracted the interest of generations of molecular biologists. Its function as a transducer of DNA methylation, the major post-biosynthetic modification found throughout genomes, and its association with the neurodevelopmental disease Rett syndrome highlight its central role as a transcriptional regulator, and, at the same time, poses puzzling questions concerning its roles in physiology and pathology. The classical model of the MeCP2 function predicts its role in gene-specific repression through the binding of methylated DNA, via its interaction with the histone deacetylases and co-repressor complexes. This view has been questioned and, intriguingly, new roles for MeCP2 as a splicing modulator and as a transcriptional activator have been proposed. Recent data have demonstrated that MeCP2 is extremely abundant in the neurons, where it reaches the level of histone H1; it is widely distributed, tracking the methylated CpGs, and regulates repetitive elements expression. The role of MeCP2 in maintaining the global chromatin structure is further sustained by its involvement in other biologically relevant phenomena, such as the Line-1 repetitive sequences retrotransposition and the pericentromeric heterochromatin clustering during cellular differentiation. These new concepts renew the old view suggesting a role for DNA methylation in transcriptional noise reduction, pointing to a key role for MeCP2 in the modulation of the genome architecture.

Keywords: DNA methylation; MECP2; Rett syndrome; chromatin; epigenetics.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) An example of MeCP2 mediated transcriptional repression: the methyl-DNA binding domain (MBD) binds methylated CpG sites and recruits histone deacetylases and co-repressors (Sin3A), inducing chromatin compaction and gene silencing (Nan et al., 1998; Chen et al., 2003; Klose and Bird, 2003). (B) MeCP2 is able to activate the transcription of some genes in hypothalamus, by binding unmethylated promoters and recruiting CREB1 and, potentially, co-activators (Chahrour et al., 2008). (C) MeCP2 is responsible for the silencing of Dlx5/6 imprinted locus by inducing the formation of a silent higher order chromatin loop (Horike et al., 2005).
FIGURE 2
FIGURE 2
Clustering of pericentromeric heterochromatin domains (chromocenters, blue spots) during myogenic differentiation of C2C12 myoblasts to myotubes (Brero et al., 2005).

Similar articles

Cited by

References

    1. Agarwal N., Becker A., Jost K. L., Haase S., Thakur B. K., Brero A., Hardt T., Kudo S., Leonhardt H., Cardoso M. C. (2011). MeCP2 Rett mutations affect large scale chromatin organization. Hum. Mol. Genet. 20 4187–4195 - PubMed
    1. Agarwal N., Hardt T., Brero A., Nowak D., Rothbauer U., Becker A., Leonhardt H., Cardoso M. C. (2007). MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 35 5402–5408 - PMC - PubMed
    1. Amir R. E., Van den Veyver I. B., Wan M., Tran C. Q., Francke U., Zoghbi H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 185–188 - PubMed
    1. Ballas N., Lioy D. T., Grunseich C., Mandel G. (2009). Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12 311–317 - PMC - PubMed
    1. Ben-Shachar S., Chahrour M., Thaller C., Shaw C. A., Zoghbi H. Y. (2009). Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum. Mol. Genet. 18 2431–2442 - PMC - PubMed

LinkOut - more resources